Don't get left behind! The modernized ClinicalTrials.gov is coming. Check it out now.
Say goodbye to ClinicalTrials.gov!
The new site is coming soon - go to the modernized ClinicalTrials.gov
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Comparing Manual Versus Stapled Side to Side Ileocolic Anastomosis in Crohn's Disease (HAND2END)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT05246917
Recruitment Status : Recruiting
First Posted : February 18, 2022
Last Update Posted : May 31, 2022
Sponsor:
Information provided by (Responsible Party):
Vittoria Bellato, IRCCS San Raffaele

Tracking Information
First Submitted Date  ICMJE February 9, 2022
First Posted Date  ICMJE February 18, 2022
Last Update Posted Date May 31, 2022
Actual Study Start Date  ICMJE May 25, 2022
Estimated Primary Completion Date December 31, 2023   (Final data collection date for primary outcome measure)
Current Primary Outcome Measures  ICMJE
 (submitted: February 9, 2022)
6 months endoscopic recurrence of endoscopy using the modified Rutgeerts classification. [ Time Frame: 6 months ]
The comparison of 6 months endoscopic recurrence between local and central reading of recordings of endoscopy using the modified Rutgeerts classification.
Original Primary Outcome Measures  ICMJE Same as current
Change History
Current Secondary Outcome Measures  ICMJE
 (submitted: February 9, 2022)
  • Morbidity [ Time Frame: 1 year ]
    postoperative morbidity measure
  • Clinical Recurrence [ Time Frame: 1 year ]
    Clinical and surgical recurrence using Clavien Dindo
  • Inflammatory Bowel Disease Questionnaire (IBDQ) [ Time Frame: 1 year ]
    Quality of life measured with IBD questionnaire
  • Hospital Costs [ Time Frame: 1 year ]
    Hospital costs per patient in both groups
Original Secondary Outcome Measures  ICMJE Same as current
Current Other Pre-specified Outcome Measures Not Provided
Original Other Pre-specified Outcome Measures Not Provided
 
Descriptive Information
Brief Title  ICMJE Comparing Manual Versus Stapled Side to Side Ileocolic Anastomosis in Crohn's Disease
Official Title  ICMJE Rct in croHn's Disease: Comparing mANual (End to End and Kono-s) Versus stapleD Side TO Side Ileocolic Anastomosis (HANDTOEND)
Brief Summary

RESEARCH QUESTION Are handsewn (end to end and Kono S side to side) anastomoses superior to side to side stapled anastomosis after ileocolic resection for Crohn's disease with respect to endoscopic recurrence, gastrointestinal function and costs.

HYPOTHESIS Stapled side anastomosis advised in ECCO guidelines heal with ulcerations on the staple line causing systematic over scoring of endoscopic recurrence leading to unjustified restarting of expensive drugs reducing QOL and increasing costs. Side to side saccular configuration causes stasis affecting recurrence and dysfunction.

DESIGN Randomised superiority study

POPULATION Patients with Crohn requiring (re)resection of the (neo)terminal ileum

INTERVENTION Kono S and end to end hand sewn anastomosis

USUAL CARE Side to side stapled anastomosis

OUTCOME Endoscopic recurrence (local and central reading) at 6 months

SAMPLE 25% reduction in 2:1 ratio -> 126 + 63 = 189 patients

KEYWORDS Crohn, ileocolic resection, recurrence

Detailed Description Not Provided
Study Type  ICMJE Interventional
Study Phase  ICMJE Not Applicable
Study Design  ICMJE Allocation: Randomized
Intervention Model: Parallel Assignment
Intervention Model Description:
Randomised superiority study
Masking: Single (Outcomes Assessor)
Primary Purpose: Treatment
Condition  ICMJE
  • Crohn Disease
  • IBD
  • Ileocolitis
  • Crohn's Ileocolitis
Intervention  ICMJE Procedure: Handsewn anastomosis
To perform hand sewn anastomosis (either end to end or Kono-s) during the reconstruction face of ileocolic resection
Study Arms  ICMJE
  • Experimental: Handsewn ileocolic anastomosis

    Randomised comparison of handsewn (end-to-end and the Kono-S) with the side-to-side stapled anastomosis.

    to use a manual anastomosis technique avoiding stapled technique to verify if stapled anastomosis can cause ulcers at endoscopic follow up with systematic overscoring

    Intervention: Procedure: Handsewn anastomosis
  • No Intervention: Side to side stapled anastomosis

    Randomised comparison of handsewn (end-to-end and the Kono-S) with the side-to-side stapled anastomosis.

    to use a manual anastomosis technique avoiding stapled technique to verify if stapled anastomosis can cause ulcers at endoscopic follow up with systematic overscoring

Publications * Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status  ICMJE Recruiting
Estimated Enrollment  ICMJE
 (submitted: February 9, 2022)
189
Original Estimated Enrollment  ICMJE Same as current
Estimated Study Completion Date  ICMJE December 31, 2024
Estimated Primary Completion Date December 31, 2023   (Final data collection date for primary outcome measure)
Eligibility Criteria  ICMJE

Inclusion Criteria:

  • Males and females aged >18 years
  • Ileocolic disease or disease of the neoterminal ileum with an indication for resection
  • Concurrent therapies with corticosteroids, 5-ASA drugs, thiopurines, MTX, antibiotics, and anti-TNF therapy are permitted.
  • All patients should have undergone a colonoscopy and MR enterography (or CT enterography if MR contraindicated) in last 3 months to assess extent of disease.
  • Ability to comply with protocol.
  • Competent and able to provide written informed consent.
  • Patient must have been discussed in the local MDT

Exclusion Criteria:

  • Inability to give informed consent.
  • Patients less than 16 years of age.
  • Patients undergoing repeated ileocolic resection.
  • History of cancer < 5 years which might influence patients prognosis
  • Emergent operation. Pregnant or breast feeding.
Sex/Gender  ICMJE
Sexes Eligible for Study: All
Ages  ICMJE 18 Years to 99 Years   (Adult, Older Adult)
Accepts Healthy Volunteers  ICMJE No
Contacts  ICMJE
Contact: vittoria bellato, MD +447827422840 vittoria.bellato@gmail.com
Listed Location Countries  ICMJE Italy
Removed Location Countries  
 
Administrative Information
NCT Number  ICMJE NCT05246917
Other Study ID Numbers  ICMJE 5.2
Has Data Monitoring Committee No
U.S. FDA-regulated Product
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
IPD Sharing Statement  ICMJE
Plan to Share IPD: No
Current Responsible Party Vittoria Bellato, IRCCS San Raffaele
Original Responsible Party Same as current
Current Study Sponsor  ICMJE IRCCS San Raffaele
Original Study Sponsor  ICMJE Same as current
Collaborators  ICMJE Not Provided
Investigators  ICMJE Not Provided
PRS Account IRCCS San Raffaele
Verification Date May 2022

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP